International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 3

Mapping Natural Product Data Ecosystems for Computational Pharmacology: Phytochemical Libraries, Bioassays, Targets, Pathways, Omics Data, and Clinical Signals
Download PDF


, ,
  1. Department of AI for Marine and Terrestrial Natural Products, Faculty of Pharmaceutical Sciences, University of Oslo, Oslo, Norway.
  2. Department of Computational Metabolomics, Faculty of Pharmacy, University of Bergen, Bergen, Norway.
Citation
Vancouver
Eriksen K, Berg S, Dahl M. Mapping Natural Product Data Ecosystems for Computational Pharmacology: Phytochemical Libraries, Bioassays, Targets, Pathways, Omics Data, and Clinical Signals. Int J Pharm Phytopharmacol Res. 2025;15(3):1-18. https://doi.org/10.51847/ngYmZOExlc
APA
Eriksen, K., Berg, S., & Dahl, M. (2025). Mapping Natural Product Data Ecosystems for Computational Pharmacology: Phytochemical Libraries, Bioassays, Targets, Pathways, Omics Data, and Clinical Signals. International Journal of Pharmaceutical And Phytopharmacological Research, 15(3), 1-18. https://doi.org/10.51847/ngYmZOExlc
Download citation:   EndNote   RIS
Article Link:
Downloads: 23
Views: 80
Abstract

Natural-product computational pharmacology increasingly depends on heterogeneous data that extend from biological source identity and phytochemical composition to bioactivity, molecular targets, pathways, omics states, pharmacokinetics, safety observations, and clinical signals. Yet these data are generated under different experimental conditions, represented through incompatible identifiers and schemas, and supported by evidence of unequal maturity. This Original Taxonomy Article maps that ecosystem and proposes a multi-dimensional classification framework designed specifically for natural-product computational pharmacology. The analysis distinguishes phytochemical records from experimentally supported occurrence and quantitative composition, structure-resolved identities from names and synonyms, and spectral or computational annotations from confirmed structures. Bioassay data are classified according to assay type, endpoint, concentration context, metadata completeness, and evidential status. Target evidence is separated into measured, functional, curated, predicted, and text-derived relations, while network and pathway associations are distinguished from direct target engagement. Transcriptomic, proteomic, metabolomic, multi-omics, single-cell, and spatial data are treated as context-dependent molecular-state evidence rather than automatic mechanistic confirmation. Pharmacokinetic, toxicity, adverse-event, and clinical data are further separated according to exposure context, provenance, causal limitations, and translational proximity. The proposed taxonomy organizes data through nine top-level classes and cross-cutting dimensions of evidence mode, biological scale, computational role, provenance, evidence maturity, interoperability readiness, uncertainty, validation status, and translational proximity. It further identifies interoperability gates involving identity resolution, metadata harmonization, semantic alignment, version control, and uncertainty preservation. The framework is intended to support more auditable databases, knowledge graphs, multimodal models, candidate-prioritization systems, and translation-aware computational platforms without assuming that data aggregation removes upstream uncertainty or makes heterogeneous evidence types equivalent.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 1
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.